BeiGene Provides Update on the Ociperlimab (BGB-A1217) Clinical Development Program

Go back to BeiGene Provides Update on the Ociperlimab (BGB-A1217) Clinical Development Program
Bank of Commerce (NASDAQ: ONC) Delayed: 380.37 +25.37 (7.15%)
Previous Close $355.00    52 Week High $0.35 
Open $380.00    52 Week Low $0.35 
Day High $383.00    P/E N/A 
Day Low $368.37    EPS $0.00 
Volume 474,571